In the February 20th edition of the New York Times, Reed Abelson reports a “New Tack on a Muscle Disease.” The “new tack” is, in fact, a scaling back of ambition in muscular dystrophy (MD) research. Since identification of various genetic mutations that cause muscular dystrophies, gene transfer has been a logical goal. But because the gene is so large, and delivery to all of a patient’s muscles so difficult to achieve, gene transfer against MD has presented a formidable challenge to researchers.
BibTeX
@Manual{stream2008-178, title = {Still Life with Duchenne Muscular Dystrophy}, journal = {STREAM research}, author = {Jonathan Kimmelman}, address = {Montreal, Canada}, date = 2008, month = feb, day = 26, url = {http://www.translationalethics.com/2008/02/26/still-life-with-duchenne-muscular-dystrophy-2/} }
MLA
Jonathan Kimmelman. "Still Life with Duchenne Muscular Dystrophy" Web blog post. STREAM research. 26 Feb 2008. Web. 10 Jan 2025. <http://www.translationalethics.com/2008/02/26/still-life-with-duchenne-muscular-dystrophy-2/>
APA
Jonathan Kimmelman. (2008, Feb 26). Still Life with Duchenne Muscular Dystrophy [Web log post]. Retrieved from http://www.translationalethics.com/2008/02/26/still-life-with-duchenne-muscular-dystrophy-2/
Leave a Reply